These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33302022)

  • 1. Menin-MLL inhibitor blocks progression of middle ear cholesteatoma in vivo.
    Yamamoto-Fukuda T; Akiyama N; Tatsumi N; Okabe M; Kojima H
    Int J Pediatr Otorhinolaryngol; 2021 Jan; 140():110545. PubMed ID: 33302022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Regulation as a New Therapeutic Target for Middle Ear Cholesteatoma.
    Yamamoto-Fukuda T; Akiyama N; Hirabayashi M; Shimmura H; Kojima H
    Otol Neurotol; 2023 Mar; 44(3):273-280. PubMed ID: 36593557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keratinocyte Growth Factor (KGF) Modulates Epidermal Progenitor Cell Kinetics through Activation of p63 in Middle Ear Cholesteatoma.
    Yamamoto-Fukuda T; Akiyama N; Takahashi M; Kojima H
    J Assoc Res Otolaryngol; 2018 Jun; 19(3):223-241. PubMed ID: 29549594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratinocyte growth factor signaling promotes stem/progenitor cell proliferation under p63 expression during middle ear cholesteatoma formation.
    Yamamoto-Fukuda T; Akiyama N
    Curr Opin Otolaryngol Head Neck Surg; 2020 Oct; 28(5):291-295. PubMed ID: 32796271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KGFR as a possible therapeutic target in middle ear cholesteatoma.
    Yamamoto-Fukuda T; Akiyama N; Shibata Y; Takahashi H; Ikeda T; Kohno M; Koji T
    Acta Otolaryngol; 2014 Nov; 134(11):1121-7. PubMed ID: 25315911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The significance of keratinocyte in hyperproliferation of middle ear cholesteatoma].
    Zhu Z; Hong Y; Wang Y; He G; Ye S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jan; 30(2):139-43. PubMed ID: 27192911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratinocyte growth factor (KGF) induces stem/progenitor cell growth in middle ear mucosa.
    Yamamoto-Fukuda T; Akiyama N; Kojima H
    Int J Pediatr Otorhinolaryngol; 2020 Jan; 128():109699. PubMed ID: 31614241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Super-enhancer Acquisition Drives FOXC2 Expression in Middle Ear Cholesteatoma.
    Yamamoto-Fukuda T; Akiyama N; Kojima H
    J Assoc Res Otolaryngol; 2021 Jul; 22(4):405-424. PubMed ID: 33861394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo over-expression of KGF mimic human middle ear cholesteatoma.
    Yamamoto-Fukuda T; Akiyama N; Shibata Y; Takahashi H; Ikeda T; Koji T
    Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):2689-96. PubMed ID: 25138153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratinocyte growth factor and its receptor expression in chronic otitis media with and without cholesteatoma.
    Harabagiu OE; Cosgarea M; Mogoantă CA; Leucuţa DC; Maniu AA
    Rom J Morphol Embryol; 2017; 58(4):1333-1338. PubMed ID: 29556625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratinocyte growth factor and receptor mRNA expression in cholesteatoma of the middle ear.
    Ishibashi T; Shinogami M; Kaga K; Fukaya T
    Acta Otolaryngol; 1997 Sep; 117(5):714-8. PubMed ID: 9349868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.
    Tanaka Y; Kojima H; Miyazaki H; Koga T; Moriyama H
    Laryngoscope; 1999 Jul; 109(7 Pt 1):1102-7. PubMed ID: 10401849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
    Sanković-Babić S; Sofronić-Milosavljević Lj
    Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of keratinocyte growth factor (KGF) and its receptor in a middle-ear cavity problem.
    Yamamoto-Fukuda T; Takahashi H; Koji T
    Int J Pediatr Otorhinolaryngol; 2012 Jan; 76(1):76-81. PubMed ID: 22024578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratinocyte Growth Factor Stimulates Growth of p75
    Yamamoto-Fukuda T; Akiyama N; Tatsumi N; Okabe M; Kojima H
    Am J Pathol; 2022 Nov; 192(11):1573-1591. PubMed ID: 36210210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Keratinocyte growth factor and its receptor in middle-ear cholesteatoma].
    Guzińska-Ustymowicz K; Kurzyna A; Trzpis K; Kemona A; Hassmann-Poznańska E
    Otolaryngol Pol; 2013; 67(2):67-71. PubMed ID: 23452652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin L activity and its inhibitor in human otitis media.
    Kusunoki T; Nishida S; Murata K; Kobashi K; Nakatani H; Hiwasa T; Tomura T
    J Otolaryngol; 2001 Jun; 30(3):157-61. PubMed ID: 11771045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of keratinocyte growth factor and its receptor in noncholesteatomatous and cholesteatomatous chronic otitis media.
    Yamamoto-Fukuda T; Takahashi H; Terakado M; Hishikawa Y; Koji T
    Otol Neurotol; 2010 Jul; 31(5):745-51. PubMed ID: 20502381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menin regulates the serine biosynthetic pathway in Ewing sarcoma.
    Svoboda LK; Teh SSK; Sud S; Kerk S; Zebolsky A; Treichel S; Thomas D; Halbrook CJ; Lee HJ; Kremer D; Zhang L; Klossowski S; Bankhead AR; Magnuson B; Ljungman M; Cierpicki T; Grembecka J; Lyssiotis CA; Lawlor ER
    J Pathol; 2018 Jul; 245(3):324-336. PubMed ID: 29672864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of NLRP3 inflammasome in human middle ear cholesteatoma and chronic otitis media.
    Kariya S; Okano M; Zhao P; Kataoka Y; Yoshinobu J; Maeda Y; Ishihara H; Higaki T; Nishizaki K
    Acta Otolaryngol; 2016; 136(2):136-40. PubMed ID: 26457439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.